Biggest News Aggregation in the World
📰 Cute News

Page 83 - Cute News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cute. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Servier submits a Marketing Authorization Application to the European Medicines Agency (EMA) for TIBSOVO (ivosidenib tablets) for patients with IDH1-mutated Acute Myeloid Leukemia (AML) and Cholangiocarcinoma

- TIBSOVO is an inhibitor of the mutated isocitrate dehydrogenase-1(IDH1) enzyme - TIBSOVO is the first IDH1 mutation specific targeted therapy submitted in Europe - The submission
France General Prnewswire Servier Kostenloser Wertpapierhandel Claude Bertrand Philippe Gonnard European Union

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science